CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,263
- in 2 filings
Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-08-05 | WHITFIELD ROY A Director | Exercise or conversion | +12,500 | $11.41 | $143K | 32,500 |
| 2013-08-05 | WHITFIELD ROY A Director | Sale | −12,500 | $12.41 | $155K | 20,000 |
| 2013-08-05 | WHITFIELD ROY A Director | Exercise or conversion · Stock Option | −12,500 | 0 | ||
| 2013-02-06 | Thomsen Jillian B. VP & Chief Accounting Officer | Grant or award · Stock Option | +37,500 | 37,500 | ||
| 2013-02-06 | Thomsen Jillian B. VP & Chief Accounting Officer | Grant or award · Stock Option | +37,500 | 37,500 | ||
| 2013-02-06 | Hora Maninder SVP Pharma Dev and Mfg | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Hora Maninder SVP Pharma Dev and Mfg | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Medve Robert Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Medve Robert Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Ghosh Rinko Chief Business Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Ghosh Rinko Chief Business Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Doberstein Stephen K Chief Scientific Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Doberstein Stephen K Chief Scientific Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2013-02-06 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +92,500 | 92,500 | ||
| 2013-02-06 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +92,500 | 92,500 | ||
| 2013-02-06 | Labrucherie Gil M SVP & General Counsel | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2013-02-06 | Labrucherie Gil M SVP & General Counsel | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2013-02-06 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2013-02-06 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2013-02-01 | GREER R SCOTT Director | Exercise or conversion | +7,500 | 50,833 |
Page 68 of 69 · 1,361 trades